Bass Gets Fed. Circ. Win On Drug Patent From Sidelines
By Bryan Koenig ( November 15, 2017, 7:01 PM EST) -- A Federal Circuit panel on Wednesday needed neither a lengthy analysis nor participation by the patent-challenging group founded by hedge fund manager Kyle Bass to uphold a Patent Trial and Appeal Board decision nixing most claims of a patent on Shire PLC's short bowel syndrome drug Gattex....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.